Using a serum TGF-β1 of value > 39.9 ng/mL and CA19-9 cut-off greater than 37 U/mL, CCA cases could be discriminated from the non-CCA, and correctly classified at 82%. The gene discussed is TGFB1; the disease is cholangiocarcinoma.